Trial · NCT01170663
Adverse events466
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 466
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Ramucirumab and Paclitaxel | 110 | 327 | 261 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo and Paclitaxel | 116 | 329 | 274 |
| other | Leukopenia | Blood and lymphatic system disorders | Ramucirumab and Paclitaxel | 111 | 327 | 471 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo and Paclitaxel | 69 | 329 | 199 |
| other | Neutropenia | Blood and lymphatic system disorders | Ramucirumab and Paclitaxel | 174 | 327 | 878 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo and Paclitaxel | 102 | 329 | 247 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Ramucirumab and Paclitaxel | 43 | 327 | 103 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo and Paclitaxel | 20 | 329 | 37 |
| other | Abdominal distension | Gastrointestinal disorders | Ramucirumab and Paclitaxel | 20 | 327 | 27 |
| other | Abdominal distension | Gastrointestinal disorders | Placebo and Paclitaxel | 20 | 329 | 25 |
| other | Abdominal pain | Gastrointestinal disorders | Ramucirumab and Paclitaxel | 98 | 327 | 165 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo and Paclitaxel | 62 | 329 | 104 |
| other | Abdominal pain upper | Gastrointestinal disorders | Ramucirumab and Paclitaxel | 31 | 327 | 48 |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo and Paclitaxel | 35 | 329 | 52 |
| other | Ascites | Gastrointestinal disorders | Ramucirumab and Paclitaxel | 31 | 327 | 46 |
| other | Ascites | Gastrointestinal disorders | Placebo and Paclitaxel | 25 | 329 | 39 |
| other | Constipation | Gastrointestinal disorders | Ramucirumab and Paclitaxel | 70 | 327 | 95 |
| other | Constipation | Gastrointestinal disorders | Placebo and Paclitaxel | 71 | 329 | 89 |
| other | Diarrhoea | Gastrointestinal disorders | Ramucirumab and Paclitaxel | 105 | 327 | 250 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo and Paclitaxel | 76 | 329 | 126 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01170663/events